RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 February 2009

On 18 December 2008, the European Medicines Agency (EMEA) published its proposed policy for making public the agency's documents. Comments on the proposed policy are due by 2 March 2009. The policy's scope extends to human and veterinary medicinal products. The policy does not apply to working documents, only documents where the decision-making process has been concluded. It includes a provision for redacting documents for the protection of confidentiality and personal data. EMEA proposes implementing the public access policy in two phases. The first phase concentrates on adequate follow-up to written requests for access to documents. The second phase includes the gradual population of an electronic registry of EMEA documents on the agency's website.


© 2022 Regulatory Affairs Professionals Society.